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Principal Investigators’ Foreword 
Providing care closer to home - the need for community based eye services 
 
This report summarises our evaluation of four different pathfinder services for people with wet Age Related 
Macular Degeneration (wet AMD). They are provided in the community setting rather than the hospital. 
Based on our findings we make recommendations about the delivery and sustainability for the future of such 
community based services for people with wet AMD in Wales. 
 
AMD is the leading cause of sight loss in Wales1and the UK and is one of the most urgent public health issues. 
The workload associated with wet AMD treatment is growing rapidly due to the ageing population and the 
regular long term follow up visits required by patients. Wet AMD is treated with injections directly into the 
eye. They have to be given at regular intervals and clinics struggle or fail to meet the recommended timings. 
Unfortunately, reports suggest that treatment times are often delayed by the increased demand for hospital 
eye services. The waiting times for treatment may result in further deterioration in the condition and sight. 
 
A Welsh Government report states that in 2013-2014 approximately 15,000 treatments for wet AMD were 
provided at a cost of £16 million2. The commitment to patients experiencing wet AMD results in a 
considerable workload for hospital eye services. Each person once diagnosed with wet AMD initially requires 
three injections at one monthly intervals and then, depending on which anti-vascular endothelial growth 
factor (anti-VEGF) drug is used, further injections at intervals of either 4 or 8 weeks, depending upon 
response to treatment and the anti-VEGF regime used. Wet AMD is a long-term chronic eye condition which 
may require treatment over many years. 
 
Wales is not alone in facing the pressures of increasing demand and insufficient capacity. However, of the 
four UK nations, Wales has the highest percentage of people aged over 65 years and this is projected to 
increase by 36.6% between 2016 and 20413. In light of the demographic pressures, changes need to be made   
to   the   way   that   wet   AMD   services    are   provided    to   ensure   they   are    sustainable.    The Welsh 
Government is committed to modernising services and providing more care and support closer to home4. 
This approach facilitates care in the community by investing in primary care and community based services 
normally provided by the hospital. In 2015 the Welsh Government made available £0.5m to fund four wet 
AMD pathfinder services in the community. It was considered important to capture and learn from 
 
1 https://gov.wales/statistics-and-research/eye-care/?lang=en 
2 https://gov.wales/about/cabinet/cabinetstatements/previous-administration/2014/eyecare/?lang=en 
3 https://gov.wales/statistics-and-research/national-population-projections/?lang=en 
4 https://gov.wales/topics/health/nhswales/plans/eye_plan/?lang=en 
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the pathfinder experiences and share what worked and learn from what did not work so well. To do that we 
were commissioned to conduct a service evaluation of the four pathfinder services. 
 
In this report we present our findings and make seven high level recommendations about the delivery and 
sustainability of wet AMD services in the community. 
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Introduction 
 
 
 
Wet Age Related Macular Degeneration (wet 
AMD) is a long-term eye condition, which may 
require treatment over many years. Wales is not 
alone in facing the challenges of increasing 
demand for treatment and insufficient service 
capacity. Wet AMD is a major cause of sight loss in 
Wales, given the demographic changes in our 
population with an increasing number of older 
people we will need to find a different way of 
meeting the needs of our patients. 
 
At present, wet AMD is treated by injecting anti- 
VEGF drugs. Two are available for use in Wales, 
Ranibizumab (Lucentis) and Aflilbercept (Eylea). 
The drugs are injected directly into the eye. The 
treatment slows or arrests the progress of wet 
AMD but it is not a cure for the condition. Active 
treatment    and    subsequent    monitoring   puts 
pressure    on    already    stretched    hospital  eye 
services and other support services in secondary 
care. To be able to provide effective treatment and 
care, changes are needed in the way that services 
are delivered to make them sustainable and 
accessible to people now and in the future. 
 
The recommendations below aim to increase 
capacity by streamlining the patient journey. The 
overall aim is to: 
 increase capacity in wet AMD services by 
reducing the number of unnecessary 
referrals into the hospital eye service 
(Referral Refinement). 
 reduce the number of review 
appointments required by considering the 
choice of anti-VEGF drug for treatment and 
follow up schedule of injections (e.g. Treat 
and Extend) 
 ensure that patients are not staying in the 
service longer than necessary by having a 
clearly defined discharge policy. 
We recommend establishing one community 
based wet AMD service pathway for Wales 
underpinned by five principles of care for 
designing, developing and delivering the pathway 
to ensure it is sustainable. The recommended 
pathway consists of five core elements - referral 
refinement, review, treat, monitoring of patients 
considered stable patients and a discharge policy. 
 
The   underpinning   five   principles   of   care are 
essential and all should be practiced in all services 
for all patients. 
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1. Putting people first: listening, learning and 
responding to patients, their family, their 
carers and their needs. 
2. Co-production: ensuring an inclusive 
approach to planning, development and 
service delivery and including staff who 
work and deliver the service, the patients, 
their families and carers and include third 
sector representation. 
3. Data gathering: nurturing a culture of 
collecting and monitoring patients’ 
outcomes as well as the health care activity 
needed to provide the service. 
4.  Standardise practice: building a culture of 
creating and using competencies, practices 
and procedures to reduce risk, increase 
staff confidence in their extending roles 
and improve the patient experience. 
5. Leadership of services: Identifying a 
central person who negotiates effective 
‘working together’ practices and seamless 
communications between services staff 
and patients. 
 
In this report we evaluated three University Health 
Boards (UHB) and one teaching Health Board (tHB) 
pathfinder services. Each HB put forward a 
different model for provision of care for patients 
with wet AMD which reflected their local needs 
and resources. The implementation of the 
pathfinder services was not always as envisioned 
in the proposals, reflecting local issues and 
changing circumstances. 
Elements of our recommended pathway can be 
seen in all of the participating pathfinder services 
as follows 
 
 Aneurin Bevan UHB: Referral refinement 
service for suspected wet AMD patients by 
staff in a community optometric practice. 
Diagnosis is made by a consultant (via a 
virtual clinic) at the hospital. Patients are 
reviewed, treated and monitored in a 
community based Ophthalmic Diagnostic 
Treatment Centre (ODTC) staffed from the 
local hospital eye service which has a nurse 
led injection service. 
 Hywel Dda UHB. Review and treatment of 
patients by hospital eye service staff in a 
community care resource centre with 
monitoring of ‘stable’ patients by 
optometrists in their community based 
practices. 
 Cwm Taf UHB: Monitoring of ‘stable’ 
patients by hospital eye service 
optometrists in the community at a Health 
Park. 
 Powys Teaching tHB: Review, treatment 
and monitoring of patients by trained 
community optometrists supported by 
hospital eye service medical staff in a 
community hospital. 
 
Our evaluation was commissioned to assess the 
pathfinder services and to answer four main 
questions: 
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 How did the wet AMD services change? 
 What was the impact upon clinical 
outcomes for patients? 
 What were the stakeholders (patients, 
carers and staff) experiences/views of the 
change of service? 
 What were the costs and consequences of 
the investment in the pathfinder services? 
 
In this final report we have made seven high level 
recommendations to the Welsh Government. We 
acknowledge the challenges of austerity and 
demography and these are accommodated in our 
recommendations. Importantly the 
recommendations also prioritise the needs of the 
patients by improving their experiences and their 
visual outcomes. Implementing these changes 
should optimise the use of health care 
professionals and HB staff time within constrained 
budgets. 
 
A description of the methodology and methods we 
used to undertake this evaluation are in Annex A. 
 
High Level Recommendations 
 
Recommendation 1: One pathway with 
five core elements 
 
A standardised community pathway for Wales 
would include: 
1. Referral Refinement; 
2. Review; 
3. Treat; 
4. Monitoring of Patients Considered Stable; 
5. Discharge policy. 
We acknowledge that implementing all elements 
may not be suitable for all HBs. Some may choose 
to implement one or two of the elements 
depending on the additional capacity required, 
demography, geography, locations of the people 
in need and staff available. 
 
Recommendation 2: Five principles of 
care for designing, developing and 
delivering a sustainable pathway 
 
Underpin the community service pathway with 
five principles of care: 
1. Putting people first: listening, learning and 
responding to patients, their family and 
their carers and their needs. 
2. Co-production: ensuring an inclusive 
approach to planning, development and 
service delivery and include staff who work 
and deliver the service, the patients, their 
families and carers and include third sector 
representation. 
3. Data gathering: nurturing a culture of 
collecting and monitoring patients’ 
outcomes as well as the health care activity 
needed to provide the service. 
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practices. 
4.  Standardise practice: building a culture of 
creating and using competencies, practices 
and procedures to reduce risk, increase 
staff confidence in their extending roles and 
improve the patient experience. 
5. Leadership of services: Identifying a central 
person who negotiates effective ‘working 
together’ practices and seamless 
communications between services staff and 
patients. 
 
Recommendation 3: Harnessing the 
professional resources and talents to 
benefit patients 
 
 
To expand capacity and reduce the pressure on 
ophthalmologists’ workload, non-medical health 
care professionals (e.g. optometrists, nurses, and 
orthoptists) should be trained to provide elements 
of the care pathway including injection 
treatments. Additionally the community 
optometric workforce can increase capacity. 
Community optometrists are ideally situated for 
patient convenience and for carrying out referral 
refinement and to monitor stable patients in their 
Recommendation 4: Nationally agreed 
competencies and training for non- 
medical Health Care Professionals 
Standard procedures for 
wet AMD community 
based services should be 
developed through 
working together with 
patients, their family and 
staff. This will ensure that their needs and 
experiences are at the forefront of service 
planning, design and monitoring. 
 
All medical and non- 
medical staff 
providing eye 
injections should be 
appropriately trained 
to  provide  the same 
good quality service, so patients have confidence 
that they will receive a consistently good 
experience. Therefore, competencies required to 
undertake eye injections should be agreed 
nationally for all healthcare professionals. The 
injection service should have regular patient 
feedback, record adverse events and be audited 
with findings acted upon if necessary. 
There are no specific 
competencies or training 
currently available in Wales or 
UK for roles and skills required 
for the elements of the new 
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recommended pathway. A working group should 
be set up to consider the training and assessment 
requirements. 
 
Recommendation 5: Creating a person- 
centred appointment experience for 
people with wet AMD 
Attention 
must be 
paid  to 
ensure 
that HBs 
provide   a 
person-centred appointment system for follow up 
care. A reliable and person-centred appointment 
system leads patients to feel confident and results 
in them believing in the system. Many of the 
worries and frustrations experienced by patients 
regarding their appointments could be alleviated 
by the provision of the date of their next visit when 
they leave the clinic. 
 
Recommendation 6: Embedding 
information technology and data 
collection into wet AMD pathways 
Information 
technology 
should support 
services,  inform 
patients of their 
care   and  enable 
easy  access  to  patient  outcomes  data. Virtual 
clinics, integrated patient records, patient flexible 
appointment systems, collecting an agreed 
minimum data-set for patient management and 
determining outcomes of care should be 
incorporated within the new pathway. 
 
Recommendation 7: Sustainable 
leadership for service delivery 
Sustainable 
leadership where 
quality and delivery 
is maintained must 
be found within a 
learning organisation. This includes the ability to 
transfer knowledge, motivate and empower 
others to lead when required, manage tension 
between the new shared vision of the pathway 
and the reality of practice. 
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Rationale for Recommendations 
 
Here we provide the reasons for developing the 
high level recommendations including learning 
from what worked and what didn’t work within 
the pathfinder wet AMD services. 
 
The bibliography can be found in Annex B. 
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Recommendation 1: One pathway with 
five core elements 
‘you are part of the whole sort of business of it [...] 
you are treated as a person.’ 
 
Providing a wet AMD 
service is a complex 
management process for 
the HBs. Our evaluation of 
the pathfinder services led us to recommend a 
single community based service pathway for 
Wales combining the experiences of the 
pathfinder services. We acknowledge that 
implementing all elements may not be suitable for 
all HBs and some may choose to implement one or 
two of the elements depending on the additional 
capacity required, demography, geography, 
locations of the people in need and staff available. 
 
Referral Refinement 
 
Referral refinement was a key component of the 
Aneurin Bevan UHB pathfinder service. Patients 
are referred directly by their optometrist or GP 
with suspected wet AMD to a specially trained 
optometrist based in a community optometric 
practice. Patients are seen within two days for eye 
scans (OCT)5 and measurement of Visual Acuity 
(VA). The findings are then sent electronically for 
‘triaging’ by ophthalmologists via a virtual clinic. 
Patients who the consultant deems to have 
suspect wet AMD are then referred to the Rapid 
Access Clinic for confirmation of diagnosis and 
treatment. 
 
What worked? 
Referral refinement allowed those patients who 
have suspect wet AMD to be identified quickly and 
referred to the Rapid Access Clinic. The triaging of 
patients resulted in approximately a third of all the 
referrals (HB Report/data) referred for urgent 
assessment. The percentage of patients receiving 
treatment within the 14 days of referral 
substantially improved which reflects the fact that 
false positives are not being referred into 
secondary care, reducing the number of 
unnecessary hospital visits. The trained 
community optometrist also had the time to 
explain the condition and what would happen 
next, giving patients more certainty around their 
likely management. 
 
What didn’t work? 
Only one pathfinder used community 
optometrists in this way, so in other HBs the 
hospital eye services continued to experience high 
level of referrals and false positives. 
 
Review and treatment 
 
After the patient is diagnosed they attend clinics 
where they are reviewed and treated. All the HBs 
implemented ‘One stop clinics’ in at least one 
location where patients are assessed and treated 
 
 
 
5 OCT is a non-invasive imaging test that uses light waves to take cross- 
section pictures of your retina. 
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at the same visit. The premises used require a 
“clean room” where eye injections can be carried 
out and where an ophthalmologist or doctor is 
available on the premises if required. 
 
What worked? 
Using a clean room in a Community Hospital, 
Community Care Resource Centre and an ODTC by 
the pathfinder services (in principle) released 
theatre and clinic space in the HB hospital eye 
services. 
 
Capacity was created by other health care 
professionals (HCPs) being upskilled to carry out 
various roles that would otherwise be undertaken 
by an ophthalmologist. Powys Teaching HB trained 
and utilised community optometrists to review 
patients and also gave the injections. Aneurin 
Bevan UHB already had a nurse led injection 
service before implementing the pathfinder 
service, which was able to move to the ODTC, 
whilst Hywel Dda UHB continued to use medical 
staff. The optometrists and nurses were primarily 
trained in house by the lead ophthalmologist in 
the service (See Recommendation 4). 
 
The frequency of follow up appointments can be 
reduced by the choice of anti-VEGF drug and 
follow up treatment regime. All HBs used Lucentis 
and Eylea , except for one (which only used 
Lucentis). Aneurin Bevan UHB had officially 
introduced the “Treat and Extend” strategy for 
their patients being treated with Lucentis and the 
other HBs were considering its implementation. By 
placing the clinics in the community setting travel 
distances were reduced by half for patients who 
were redirected to these Powys Teaching HB and 
Hywel Dda UHB pathfinder services. 
 
What didn’t work? 
The capacity of the community based services 
where a non-medical injector was used was 
constrained by the requirement to have a trained 
doctor on site (not necessarily an ophthalmologist) 
to treat any adverse reaction. In Hywel Dda UHB 
the clinic was held in a resource centre with GP 
practices on site so a GP was only available during 
morning and afternoon sessions leaving a possible 
gap in cover around mid-day. However, a lack of 
non-medical staff who wished to train or were 
trained as injectors was another constraint on 
clinic capacity. Similarly in Aneurin Bevan UHB the 
ODTC and the Community Hospital in Powys 
Teaching HB could only operate on days when the 
consultant ophthalmologist was available to be at 
the clinic. 
 
Monitoring of ‘stable’ patients 
 
In Hywel Dda UHB optometrists in their 
community practices were trained by the 
consultant ophthalmologist to monitor patients 
who are considered to be “stable” according to the 
consultant‘s review. The optometric practices 
were already equipped with the appropriate 
imaging machines (OCT) and optometrists were to 
carry out a clinical assessment (Visual acuity (VA), 
Slit lamp examination) and acquire OCT images to 
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enable them to make a decision as to whether the 
patient was still stable or need to be referred back 
for a second opinion or for treatment. 
 
The optometrists in Cwm Taf hospital eye services 
added a session at Keir Hardie Health Park to their 
rotas to review patients considered stable and 
then discharge according to clear criteria. The 
optometrists, supported by a medical 
photographer and optical technician, worked in 
other hospital eye service clinics as part of a 
multidisciplinary team in secondary care. They 
were already trained to undertake clinical 
assessment by slit lamp examination and to review 
other clinical data collected by the team, (VA and 
OCT images) to make management decisions. 
Access to consultant support for the wet AMD 
pathfinder service is available, via a virtual clinic, if 
required which is a valued safety net for 
optometrists and patients. 
 
A ‘Monitor and Extend’ regime for ‘stable’ patients 
was introduced that can reduce the number of 
visits required. If a patient is ‘stable’ and does not 
require an injection, their follow up period is 
extended by 2 weeks (4, 6, 8 weeks etc to a 
maximum of 12 weeks). If a patient remains stable 
for 12 months without injection, they are 
discharged back to their local optometrist. 
 
What didn’t work? 
In Hywel Dda UHB the community based stable 
follow up service looked very promising initially, 
and embraced with considerable enthusiasm by 
the community optometrists. The consultant was 
the critical link in the chain deciding who would be 
discharged to stable follow up by the community 
based optometrists. However when the 
consultant ophthalmologist went on long term sick 
leave the service was not continued as there were 
no protocols or standard operating procedures in 
place to decide who should be discharge to the 
community service (See Recommendation 3 and 
4). 
 
In Cwm Taf UHB the service had low take up which 
resulted in clinics working under capacity due to a 
low number of patients considered to be eligible 
who lived in the catchment area. 
 
Different criteria for discharge appear to be used 
by different consultants in different HBs and some 
staff were unaware of the criteria. 
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Recommendation 2: Five principles of 
care for designing, developing and 
delivering a sustainable pathway 
‘I’ve asked the people there [clinic] questions and 
I’ve always had a good answer.’ 
 
‘it makes all the difference, I’ve got a contact, 
there’s a young lady called [name] who makes all 
the appointments […] it’s always good to have a 
contact, someone you can ring up if you’re worried 
about anything.’ 
 
‘right from the start, from the bottom level up, 
rather than the top level down, because it’s much 
easier for people on the floor if they know that the 
service is going to be set up.’ 
 
 
 
 
The community service pathway should be 
underpinned by the following five principles of 
care: 
1. Putting people first: listening, learning 
and responding to patients, their family 
and their carers and their needs. 
2. Co-production: ensuring an inclusive 
approach to planning, development 
and service delivery and include staff 
who work and deliver the service, the 
patients, their families and carers and 
include third sector representation. 
3. Data gathering: nurturing a culture of 
collecting and monitoring patients’ 
outcomes as well as the health care 
activity needed to provide the service. 
4. Standardise practice: building a culture 
of creating and using competencies, 
practices and procedures to reduce 
risk, increase staff confidence and 
improve the patient experience. 
5. Leadership of services: Identifying a 
central person who negotiates 
effective ‘working together’ practices 
and seamless communications 
between services staff and patients. 
 
We based the five principles of care for community 
based wet AMD services on what patients, their 
carers and family voiced and also what the staff 
providing and supporting the services told us. 
Whilst much of what we heard was good, people 
were honest and told us what did not work for 
them but also gave us their views on what might 
work better. 
 
What worked? 
Patients, their families and staff valued clinics 
where there was a culture of listening, learning 
and responding to their needs. They interpreted 
this as a caring environment where they 
appreciated a certain standard of care. 
Information, counselling and treatment timeliness 
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enabled patients to make sense of what was 
happening to them, be able to consider the 
options available and understand how managing 
the long term condition would impact on their 
independence and daily life routines such as 
voluntary work, going on holiday and caring for 
family members. What helped this process was an 
identified key central person who carefully and 
consistently communicated the pathway vision, 
instilling confidence and resulting in patients 
feeling safe, more likely to accept the treatment 
regime; and they also earned great respect from 
fellow staff. 
 
It was important to the patients in every 
pathfinder service that we understood that they 
would do anything to protect their sight and their 
independence. Initial diagnosis and sight loss 
which they described as a shock triggered anxiety 
which required each patient having to adapt their 
independent living arrangements to suite their 
variable needs. Patients and their families 
expressed mixed information needs which were 
often triggered by their own levels of 
inquisitiveness, resulting in them accessing 
information from multiple sources not just the 
clinic but from the internet, Macular Society and 
fellow patients. Therefore when patients and staff 
exchanged information about the process and 
disease this triggered a mutual appreciation which 
resulted in the patients valuing the relationships, 
having a positive experience and describing the 
staff as ‘brilliant’. 
What didn’t work? 
Where clinics were busy and there was insufficient 
individualised information, patients felt empathy, 
frustration, nervousness and worry, leading them 
to not wanting to ask questions which resulted in 
a perceived lack of individual information. They 
expressed worry at being ‘lost in the system’ or 
when they experienced a treatment delay they 
often explained the deterioration they 
experienced in visual welfare created a growing 
fear of loss of their normal activities and 
independence. 
 
Where there were problems with clinic 
accessibility, overcrowding, parking and access to 
toilets, these generally originated from the early 
planning stage. The problems improved when 
patients and staff who worked in the clinics were 
involved in the process. Some issues were still 
unresolved at the end of the evaluation period. In 
one university health board a perceived lack of 
accessible patient toilets led to patients telling us 
that they had to ask for a staff escort to go through 
a private area to access the facilities. 
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Recommendation 3: Harnessing the 
professional resources and talents to 
benefit patients 
‘I think the best thing I think for us is the breaking 
down the boundary, I mean it’s great working with 
[consultant], but now you know working alongside 
the other ophthalmologists and making them 
realise how good a job we are and how capable we 
are’ […]. They’re not aware of what we are capable 
of doing, so maybe there’s not the confidence to 
send them back into the community.’ 
 
 
 
To expand capacity and reduce the pressure on 
ophthalmologists’ workload non-medical health 
care professionals (HCPs) (e.g. optometrists, 
nurses, orthoptists) can be trained to provide 
elements of the care pathway. In addition to clinic 
based care reviewing and treating patients as part 
of a multidisciplinary team, an increasing number 
of optometrists have the imaging equipment 
(OCT) in their practices that allows them to carry 
out a variety of tasks including referral refinement 
and the monitoring of ‘stable’ patients. There is a 
community  of   optometrists  in   Wales  that  has 
demonstrated willingness to grow expertise and 
contribute more widely to patient care. 
 
What worked? 
In all the pathfinder services optometrists were 
upskilled and/or had their remit expanded to take 
a role in care that had been previously undertaken 
by a qualified ophthalmologist. The community 
optometrists responded to the opportunity with 
enthusiasm even at the expense of income to their 
community practices. The hospital eye service 
optometrists absorbed the extra wet AMD clinics 
at the Health Park with no impact on their other 
workload, seeing it as a natural extension of their 
other hospital eye service roles. 
 
What didn’t work? 
Whilst engaged in treatment of patients the role of 
the optometrist has expanded considerably, the 
referral refinement role has not developed as fully. 
The current role of optometrist for referral 
refinement is data gathering, acquiring images and 
measure vision that is triaged by a consultant (on 
site or via a virtual clinic). However, trained 
optometrists could better employ their skills to 
carry out new patient triage.6 Different levels of 
decision making for non-medical HCPs are being 
developed from image acquisition with review by 
an ophthalmologist, to HCPs acquiring images and 
proposing a treatment plan confirmed by 
consultant and autonomous HCP clinic with access 
to consultant report if needed. 
 
 
 
6 https://www.rcophth.ac.uk/wp-content/uploads/2015/10/RCOphth-The-Way-Forward-AMD-300117.pdf 
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Recommendation 4: Nationally agreed 
competencies and training for non- 
medical health care professionals 
‘You know, like the first [injector] held my hand so 
tight [...] but um the last injection I had, [injector] 
kept saying to me all the time, “hold still, hold still, 
it's coming now”. Well I worked myself up so much, 
I almost hyperventilated on the last one. But it was 
really bad. Oh my eye, I was in such a mess after 
that one. But the second injection, I didn’t even 
have any redness, didn’t have any bloodshot or 
anything. And but the third one, oh it was really 
bad for a week after.’ 
 
‘There are no formal arrangements for sending 
people back in when, or discharging them and 
stuff, and it’s OK when you’ve got [consultant] and 
you can send an e-mail and say, do you think we 
can send this, or this patient is like that […]. But 
they, but just, just as a guidance thing, there does 
need to be a bare minimum of saying, you know, 
“this is when you can get rid of the patient out of 
discharge completely, this is when you need to 
send”. You know, sending them back in is not 
something, are you happy, is it stable, well you’re 
going to keep them.’ 
 
A recognised patient pathway with protocols and 
standard operating procedures (SOPs) ensures 
assurance and certainty of role responsibility and 
results in staff meeting and adhering to expected 
standards. Formal training for all staff within a 
new service takes time but is essential if it is going 
to meet professional/service standards which is 
what patients expect. A step change approach to 
standardisation and service change builds staff 
and patient confidence which results in 
sustainability. 
 
It is  essential 
that   patients 
have confidence 
that they will 
receive    a 
consistently 
good experience of their eye injections. Both 
patients and their spouses reported some variable 
experiences of eye injections where staff had not 
completed training and competencies. Patients 
describe the injecting experience as something 
they ‘dread’ when awaiting the next appointment. 
It is important to note that patients reported that 
they endured their treatment regime because of 
their need to save their sight. 
 
‘I hate it, I honestly do hate it […]. I don’t like the 
injection in the eye, oh but I go […]. I think to myself 
I got to try and protect my eye haven’t I?’ 
‘I don’t like having them mind because they are not 
very nice at all but that is something you go to put 
up with’, ‘it’s got to be done, it’s better than going 
blind, you know. Because blindness is my greatest 
worry in life, you know if I went blind I think I would 
just shoot myself’. ‘I just clenched my fists […] it’s 
an intrusion into your body […] even after having 
23 injections, I still tense up.’ 
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Therefore all staff 
providing eye 
injections should be 
appropriately trained 
to provide the same 
good quality service 
and competencies and training should be agreed 
nationally for all healthcare professionals. The 
injection service should have regular patient 
feedback, record adverse events and be audited 
with findings acted upon if necessary. 
 
What worked? 
Non-medical HCPs are involved in all elements of 
the pathway and their training has been primarily 
provided by the consultant ophthalmologists. 
 
The need for Optometrists to practice 
independently in the pathfinder service in Cwm 
Taf UHB triggered the development of an 
unofficial training protocol with three key 
elements for the Optometrists to ‘pass’. This 
resulted in them being ‘declared independent and 
fit to start’. This is founded on a combination of 
optometrists’ previous extensive experience and 
the training instilled trust resulting in the 
consultant gaining confidence in their practice. 
 
Acknowledging risks also triggered the 
development of new service governance 
arrangements and resulted in identifying training 
needs. 
 
The initial optometrists ‘pilot’ training with one 
consultant in Hywel Dda UHB led to mutual trust 
with the outcome that standardised competencies 
and protocols were acknowledged as being 
required. Community optometrists and 
ophthalmologists working together alerted the 
need to share scan information to enable 
optometrists to review patients over time and 
provide better information. 
 
The training provided for nurses and optometrists 
undertaking injections in the pathfinder service in 
Aneurin Bevan UHB and Powys tHB respectively 
was primarily carried out in house and led by the 
consultant ophthalmologist. All injectors were 
required to carry out 100 supervised injections 
before they were considered to be competent and 
could inject unsupervised. The origins of the exact 
number of supervised injections required to be 
competent could not be verified by the staff in our 
pathfinder services. This figure was set ‘by the 
clinicians’, were ‘just a number we choose’ and not 
evidenced by ‘any published data’. ‘It’s essentially 
what we have had from other units, from 
Moorfields, that their nurses have had similar 
number of injections. So who originally came up 
with the number, I don’t know.’ 
 
‘We haven’t got the formal, the sort of higher 
qualifications […] and talking to people through it. 
And actually, having done, seen hundreds of these 
patients now, not all in the primary care, but so 
much of it is just experience, it’s just looking at the 
patients, having the notes and doing the job. And I 
think that’s really, you know, it’s, I mean 
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[consultant] said on several occasions you know, 
we’re the same quality, in terms of this particular 
piece of work, the same quality as mid grades.’ 
 
What didn’t work? 
Standard protocols were not in place in Hywel Dda 
even after investment in intensive training of the 
community based optometrists to provide the 
service, when the consultant went on sick leave 
the community based stable follow up service 
foundered. 
 
Whilst care was taken to ensure the non-medical 
HCP injectors had a prolonged training supported 
by a consultant ophthalmologist, the medical 
injectors gave the patients a more variable 
experience. Some of the medical clinicians were 
locums. 
 
‘So he won’t have him anymore. We, we have had 
him since, but fortunately that was the time when 
he didn’t need the injection. And the receptionist 
told us if, if he needed an injection, I am to say that, 
could we arrange for an injection to be done in the 
following clinic.’ 
 
‘And it, it is important from, from me or anybody 
else, to go in to have another [injection], because 
if the pain is not there, you’ll go again. And again, 
and again. If you go in once and is, hurts you 
worse, you said, “well, I will never want to, want to 
go again”. Well, that’s bad.’ 
 
’We do have a training protocol that’s not officially 
been signed off yet, but that doesn’t include 
competencies but it does include a fixed period of 
shadowing, I think it’s two weeks that we’ve got 
down on there and then also one directly observed 
patient consultation with the consultant 
observing.’ 
 
Cardiff University provides an accredited 
Professional Certificate in Medical Retina course 
(duration 30 weeks) for eye care professionals 
which includes content on AMD. Of the 18 
optometrists involved in the new services, eight 
have completed or are currently undertaking or 
are enrolled for the next course. This course 
covers a wide range of conditions, with nearly half 
of the content on diabetic retinopathy, and hence 
it is not specific for wet AMD. For non-medical 
HCPs in the community a more focused training 
programme, with agreed competencies for the 
skills required for AMD would be more 
appropriate. 
 
It is now important that clinical competencies are 
agreed nationally for the different clinical roles 
undertaken by non-medical HCPs so that 
standardised training and qualifications can be 
provided. This will ensure that the work force will 
be developed to deliver safe and efficient care in 
the community. 
 
It is recommended that a working group should be 
set up to consider the training and assessment 
requirements and how they could be 
implemented. 
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Recommendation 5: Creating person- 
centred appointment experience for 
people with wet AMD 
‘I know I have to have them [injections], so when 
that 8 weeks, then I go 9, 10, 11, that is the longest 
I have been is 11, I do start to get very anxious.’ 
 
‘Now I was told […] that the nurses were doing it, 
the lists were going to get shorter, and I would be 
having it every four to six weeks. But they haven’t 
got any shorter, they’ve got longer. Now I’ve got it 
in the other eye […] God knows what will happen 
[…] it’s ridiculous.’ 
 
’He ends up having to phone to say you know I 
haven’t had an appointment for a long time and it 
can go over twelve thirteen week period and of 
course he does then get concerned he knows he 
requires hospital eye services injections […] and he 
will never turn one down, he will never say that’s 
difficult.’ 
 
‘I put up with it until I think, oh this is it, it’s getting 
silly now, I’m having to move things around to see 
them, I can’t see faces in the TV or anything like 
that, so that’s when I phone up.’ 
 
For patient wellbeing it is very important that they 
are confident that patient appointments are 
scheduled at the correct time and that they are 
informed in good time. Late notification causes 
unnecessary anxiety and fear that they are lost in 
the system. This occurs where the monthly 
booking system triggers appointments at short 
notice and with patients ringing to chase their 
appointments. This results in patient concerns 
about sight loss and sometimes inconvenience. 
The stress that is created by the uncertainty of 
when their next appointment will be is 
considerable and affects not just them but their 
families. Changes made to appointment times 
leads to patient and supporter frustration 
resulting in them not being able to plan life events 
and holidays. 
 
A reliable and 
person-centred 
appointment 
system leads 
patients to feel 
confident  and 
results in them 
believing in the system. Many of the worries and 
frustrations experienced by patients regarding 
their appointments could be alleviated by the 
provision of the date of their next visit when they 
leave the clinic. 
 
What worked? 
Learning from this evaluation, investment in good 
clerical staff who care about the patient 
experience, understand the use of the available 
information technology and the routine software, 
the service and outcomes for patients pays 
dividends in terms of getting patients to their 
appointments and ensuring they know when their 
next appointment is to be. The staff are crucial 
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and are all part of delivering a valuable and valued 
service – information technology needs people to 
engage with it and the community of patients they 
serve. 
 
What didn’t work? 
The culture of “…the computer says” or “... this is 
the system” is all too common and in three of the 
services patients could not walk out with their next 
appointment because the system did not ‘allow’ 
this. 
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Recommendation 6: Embedding 
supportive information technology and 
data collection into wet AMD pathways 
‘you used to before, they would give you a date for 
your next appointment where sometimes, you 
could say to them […] you were going on holidays, 
or you had another appointment […]. Well you 
could say to them “I can’t do that day, could you 
do it another day?” […] but today, they don’t let 
you know until just over a week before.’ 
 
‘it would be wonderful to have something given to 
us at the end of the session, “this is what has 
happened this time, there is no change. The 
prognosis is such at this time still”. Then we can ask 
questions that are informed. At the moment, we’ve 
got nothing […] it’s often when I go home that I 
think oh why didn’t I, but there you go!’ 
 
Information technology is all pervasive in NHS 
services. Care must be taken that it does not drive 
patient care and data access. In the interim period 
before the electronic patient record is rolled out a 
positive culture of data collection and utilisation 
needs to be established and rejection of a “the 
computer says…” culture. Rather information 
technology should support services, inform care 
and enable easy access to patient outcomes data. 
We suggest that by embedding the five principles 
of care into the information technology support to 
enable virtual clinics, integrated patient records, 
appointment systems that facilitate on the spot 
‘next appointments’ before the patient leaves the 
clinic, collecting a minimum data-set for patient 
management and determining outcomes of care. 
 
All the pathfinder services 
collect/direct routine 
data from the patient 
(paper) record to various 
sources, all based on 
patient visits for 
treatment or monitoring 
and hospital IT systems 
(e.g. Merddyn). The 
hospital eye services 
systems link in with 
booking systems for 
appointments and other 
systems relating to 
services and diagnostic 
tests. Some were better ‘connected than others’. 
None of the hospital eye services routine data 
collections are intended for use in research. 
 
Some of the pathfinder services set up additional 
data collections to be able to report back on the 
Welsh Government requirements and others had 
systems in place and data analysts assigned to 
undertake data extracts for this purpose. 
 
The Electronic Medical Record (EMR) is planned 
for NHS Wales but whilst this may be necessary to 
improve communications and managing data it is 
possibly not sufficient. The HBs perhaps need to 
become more aware of the need to evaluation of 
treatment in terms of health outcomes (in this 
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case VA) as well as reporting activity. 
 
 
This project has been an exemplar from the Welsh 
Government as it has emphasised that money 
invested in services has to be evaluated for the 
outcomes the investment has enabled. A culture 
of evaluation could be developed from this project 
by Welsh Government (every grant is 
accompanied by funding for evaluation) and in the 
health boards. 
 
What worked? 
All systems have a focus on capturing information 
regarding timing of appointments and the anti- 
VEGF injections as that is what is required by 
Welsh Government for regular reporting but also, 
importantly because the timing of injections is 
crucial for optimising treatment outcomes and 
preserving sight. All patient paper based records 
have the VA at the time of the visit recorded and 
most have VA included in supplementary 
electronic data collections. 
 
Aneurin Bevan UHB had a clinician with a 
particular appreciation of the need to collect and 
analyse data on patients’ treatment, outcomes 
and using the data to undertake informative 
analysis on (amongst other things) patients’ visual 
outcomes. MS Excel was the software used – a 
software that is widespread and an excellent tool 
for data analysis. The reports the clinician has 
produced to share with Welsh Government and 
the HB are exemplary. However they are based on 
a data entered and managed by the consultant 
independently of the routine data collection. 
 
 
Powys Teaching UHB had a responsive and helpful 
team responsible for data management and had 
fairly complete data however some pertinent 
patient data remained with the service in Wye 
Valley NHS Trust. 
 
What didn’t work? 
The evaluation was compromised by the lack of 
data to enable assessment of impact on patients 
and their visual outcomes. The prevailing culture 
related to valuing data, prioritising data collection 
for its use in feedback on how patients and the 
service can benefit from information based on 
their own data varied considerably. 
 
It was clear that all the pathfinders had 
idiosyncratic systems and processes to capture 
data on top of the usual routine systems. Some 
had a focus for electronic data collection as a way 
to ‘store’ data in MS Excel or MS Access without an 
appreciation of how to set up data to enable 
analysis or reporting within these very flexible 
software tools. In one health board the recording 
of VA and entering the data at each visit into the 
local system of data capture had been started in 
one clinic but had met with some resistance in the 
clinic as it was thought to be too time consuming. 
In one HB the diagnosis and initial treatments 
were recorded in the hospital eye services at 
diagnosis but not linked to the data capture in the 
follow up services. 
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Recommendation 7: Sustainable 
leadership for service delivery 
‘But at the end of the day something has to make 
sure we develop this type of service right across 
really.’ 
 
‘that’s what’s nice here […] if we’re short you’ll see 
the consultants in there ‘dropping’ for us, you’ll see 
the consultants in there helping us lay-up trolleys 
(agreement) […] we’re all mindful of each other.’ 
 
Sustainable 
leadership where 
quality and delivery 
is maintained must 
be   found   within a 
learning 
organisation. This 
includes the ability 
to transfer 
knowledge, motivate & empower others to lead 
when required, manage tension between the new 
shared vision of the pathway and the reality of 
practice. This is especially true through periods of 
transition when a process of change has to be 
managed with patients and their supporters 
gaining a sense of continuity of service quality, as 
happened within all of the pathfinder services. 
Drawing on our five principles of care this is where 
listening, learning and responding to people 
through a co-productive process and nurturing a 
culture of data collection and standardised 
practice  can  ensure  that  should  a  team  lose  a 
leader suddenly then the baton can be handed 
safely to another person and services can be 
maintained to the same standard for patients. 
 
What worked? 
Empowered leadership committed to affecting the 
change, maintaining it, and further developing the 
service often led to a flat organisational structure 
within the new pathfinder services. In some 
services there was a sense of equality with clearly 
defined roles and sharing of knowledge within the 
multidisciplinary/ multiagency team. ‘I love the 
team, the team have a great rapport […] they are 
so willing to share their knowledge with me […]. 
[Consultant] is so good, he has really got the time 
to sit down and explain things to you and I was 
included in the conversation.’ 
 
Clearly defined roles in Brecon for example clinical 
lead, training lead, administrator (copied all notes 
into the database), optometrist injectors, support 
worker (patient reassurance), social connector 
(normalising daily life), coordinator/problem 
solver. This resulted in a flexible team who pulled 
together to fill the gaps when needed. 
 
Every pathfinder service had made a considerable 
joint effort to ‘make it work’ and the large amount 
of good will was evident throughout our 
conversations. Working together to get the job 
done was evident in the planning phase in some 
sites through multi-agency collaboration and also 
in the service delivery. So there was a shared 
expectation with regard to patient quality and 
some areas having ‘rules of engagement’. Then 
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empowering team members to plan forward 
together to continuously improve, in accordance 
to changes that were needed ‘there’s a crisis in 
[name] and I’m trying to build a pathway between 
[consultant] and [consultant] […] so another 
pathway to be considered. Because we’ve had one 
patient that got lost in the system and is no longer 
able to have treatment for wet AMD.’ 
 
Staff motivation for establishing, being a part of, 
running and maintaining the new service 
originated from a sense of excitement of being 
part of it, they were attracted by success and 
desire to develop professionally. The prospect of 
obtaining a ‘new skill’ sustained their interest and 
where they felt empowered staff felt more valued 
and recognised ‘I’ve been allowed to step forward 
more and, whereas before people didn’t perhaps 
realise or didn’t see what we did in the 
department, they now see what we do.’ 
 
Making sure that staff spent time with key people 
(‘theatre service guy, who sourced equipment’) to 
ensure confidence in service delivery worked well 
in Powys tHB and in Aneurin Bevan UHB. For the 
sites where there were HCP in extended roles it 
included making arrangements for shadowing the 
consultant. In Cwm Taf UHB it included presenting 
cases to him and considering the percentages of 
agreement between them and providing a short 
OCT exam. 
 
Co-locating a private organisation and a statutory 
organisation with multiple professionals triggered 
some initial apprehension about working 
relationships and behaviours. These included 
changing mind-sets when developing the pathway 
‘the front-end of the pathway is Optometrists […] 
“I need to refer this not to the hospital but to 
Specsavers Opticians” […] that doesn’t necessarily 
fit very easily with everybody ‘. There was some 
concern about who would be coming to work in 
the building; and establishing accountability. 
However, initial reservations had subsided over 
time and the outcome was positive; ‘they have 
been really great to work with, we love having 
them there. They are such a great bunch of 
people.’ 
 
Exploring working conditions and relationships 
with staff in the first instance prior to the move to 
Friars walk resulted in a flexible mobile team who 
work in Friars Walk in Newport and also in Ystrad 
Mynach and Neville Hall in Abergavenny. 
 
What didn’t work? 
There were some unresolved issues in some HBs 
such as transport and toilet accessibility, parking 
and extending times between appointments. It 
was apparent through our research that some 
attempt had been made to engage with statutory, 
third sector and patient groups to try and resolve 
them. However, what patients and their 
supporters told us was that these were real and 
important issues for them and in some of these 
issues they weren’t being heard. These triggered 
feelings such as uncertainty, fear, anxiety, anger, 
guilt and disappointment in a group of people who 
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on the whole are very grateful for the treatment 
available and appreciated all the staff who they 
understood worked in very busy environments. 
 
What is apparent from our research is that you can 
ask a patient and their supporters about 
satisfaction and you will likely get a response of 
between 90% and 100% of respondents who think 
the service is good or very good. However, it is 
important to listen to those people who are using 
and delivering the service to ensure that issues are 
identified and are resolved early in the planning 
stage and they are involved in changes planned 
later throughout the service pathway. 
 
At the time of the evaluation the wet AMD service 
staff, particularly the ophthalmologists in one HB 
were going through a state of change with the lead 
consultant on long term sickness leave and the 
service having to use a number of locum staff. The 
initial ‘pilot‘ training with the one consultant had 
led to mutual trust but this was not evidenced 
within standardised competencies and protocols. 
There were a number of consequences to this 
situation reported to us by patients, supporters 
and staff e.g. Patients’ variable injecting 
experiences, increasing times between 
treatments, and the reduction in ‘discharge’ 
referrals to the community optometrists. 
Therefore our seven recommendations on the 
whole provide a collective approach to support the 
sustainable leadership role within the new 
pathway for wet AMD. 
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Conclusion 
We gathered evidence from a wide range of 
sources to evaluate the four pathfinder services 
and make our seven recommendations. We would 
like to thank all those people who gave their time 
to participate. 
 
What were the stakeholders’ experiences 
of the change in service? 
Based on our survey, generally 90-100% of 
stakeholders (patients, carers) thought the wet 
AMD services were very good to good. They 
appreciated all the staff who they understood 
worked in very busy environments. However, we 
have highlighted common aspects of patient 
experience that need improvement. These include 
the importance of information giving to the 
patients and carers on their condition, care and 
treatment schedule. This would include date and 
time of appointments, from initiation of treatment 
to the phased reduction, discontinuation of 
injections and monitoring of the wet AMD. This 
allays anxiety though knowledge of their condition 
and its management puts them back in control and 
ability to get on with their life with their family. 
 
It is important that the agencies and the role of the 
third sector in support of clinical professionals is 
recognised and valued. 
 
For some patients in one health board the 
perceived lack of patient accessible toilets and 
access issues for the ambulance service for some 
very frail patients were unresolved and were 
expressed as challenging and at times 
embarrassing. The community service needs to be 
patients centred at all stages from planning, 
design, delivery and monitoring. These issues if 
addressed from the start do not need resourcing 
to any great degree, rather it is a matter of 
standing in the shoes of the stakeholders in the 
service and planning the service and systems with 
this perspective in mind. 
 
How did the wet AMD services change 
and what were the costs and 
consequences? 
In these new pathfinder services the changes in 
the service varied. Cwm Taf UHB invested in the 
equipment necessary to provide a service at a 
Health Park (Keir Hardie HP) but did not have to 
invest in more staff to provide the service there as 
there was only modest use of the service. However 
if the service were to scale up then there would be 
implications for staffing the service. 
 
Powys tHB put together a financial plan based on 
the funding requested and received from Welsh 
Government which enabled the pathfinder service 
to be delivered on plan, on budget, to the benefit 
of the patients in terms of travel times, achieving 
targets for treatment times and over the year, 
saving the health board money. Community 
optometrists were keen to enhance their roles and 
train to undertake the injections and gained 
professionally from their participation. Whilst not 
pertinent to Wales per se the hospital eye services 
in Wye Valley NHS Trust benefited from the service 
as more capacity was created in their service. 
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In Aneurin Bevan HB there were no changes in 
staff resources and related costs used to establish 
the ODTC other than the initial investment in the 
equipment, setting up and renting the town centre 
facility. The main change in the new pathfinder 
service provided at the ODTC facility is the referral 
refinement step which alleviated pressure and 
increase efficiency in the rapid access clinic and 
ODTC. The limited availability of a medically 
qualified person in the ODCT restricts expansion. 
 
Hywel Dda UHB were able to put a pathfinder 
service in place, but not as planned, nor with the 
extra staffing for which funding was available. In 
effect, the new service at Community Care 
Resource Centre (Crymych) had an opportunity 
cost as it drew staff from other locations in the HB 
to enable the service. 
 
In two of the pathfinder services the travel 
distances were reduced by half, with many 
consequent benefits for the patients attending 
clinics for monitoring and treatment. 
 
In Hywel Dda UHB Welsh Ambulance Service Trust 
(WAST) no longer transported patients who were 
transferred to the new Crymych service as this was 
not part of their contract. From the patient 
perspective, and the people who drive them to 
their appointments there was time saving and 
reduction in distance (approximately 50% of the 
journey length on average). The repatriation of 
wet AMD patients in Powys tHB patients to Brecon 
Community Hospital from Hereford hospital may 
have reduced some use of WAST transport, 
however we understand that the majority of the 
patients were driven by relatives or used public 
transport. As with Hywel Dda UHB we had no 
access to transport data but from postcode analysis 
we know the journey length was reduced by 
approximately 50%. 
 
What was the impact upon clinical 
outcomes for patients? 
The changes made to the services to deliver the 
Pathfinder projects appear to have in all cases 
maintained or improved the vision outcomes for 
patients. Given the heterogeneity inherent in the 
data given the approach the evaluation had to take, 
it is nonetheless reassuring that if we informally 
benchmark the vision outcomes for Pathfinder 
Services with the outcomes reported by Liew et al 
in 20167 the Pathfinder services are broadly similar. 
 
Our evaluation of four pathfinders delivering wet 
AMD services in the community has shown that 
each pathfinder service has elements of good 
practice. We have drawn on these to propose one 
community service pathway for Wales with five 
core elements; referral refinement, review, treat, 
monitoring of patients considered stable and a 
clearly defined discharge policy. All these 
elements can increase capacity in services. It is 
designed on the principles of prudent health care 
using resources in the community, in particular 
optometrists in their community practices who 
have the necessary imaging equipment to allow 
 
 
7 https://www.ncbi.nlm.nih.gov/pubmed/27419839 
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virtual review by ophthalmologists. This is in line 
with The Cabinet Secretary for Health who states 
that “future service models need to ensure that 
we use the full skills of the eye care work force to 
ease the pressure on the hospital based services, 
making the best use of community optometry 
services to do this.”8 
 
The multidisciplinary approach of training and up- 
skilling of nurses and optometrists to carry out 
tasks previously undertaken by ophthalmologists 
enables services to cope better with the increased 
pressures. Nurses and optometrists have been 
trained to provide injections. In addition, 
optometrists have been trained to undertake 
referral refinement (that speeds up diagnosis and 
treatment), assess and manage follow up patients 
and monitoring of stable patients. It is now 
important that nationally agreed core 
competencies are established for the delivery of 
intravitreal injections and the skills required by 
non-medical HCPs involved in the service delivery. 
Appropriate education, training and assessments 
for the skills need to be provided. Alongside this 
embedded in the services the creation of protocols 
and operating procedures in the hospital eye 
services and community services for wet AMD is 
critical to ensure continuity and high standards of 
care. 
 
The importance of creating a positive culture 
around collection of health outcomes as well as 
healthcare activity data, together with intelligent 
 
8 WG Prioritised Eye Care Plan Actions to 2018 
https://gov.wales/docs/dhss/publications/170807eye- 
healthen.pdf 
analysis and feedback into the service needs to be 
established. Creating this culture aids decision 
making, reduces risk and ensures that treatment is 
achieving its goals. There is an excellent example 
of this in one of the pathfinder services. 
 
Harnessing the information technology resources 
in the HB and NHS Wales rather than being its 
servant will enhance the patient experience, 
patient outcomes and enable all the staff engaged 
in the eye services to deliver value based health 
care. 
 
Funding will continue to be pressured due to the 
ageing population. The grants provided by the 
Welsh Government were effective in enabling the 
equipment and other capital investment to be 
made to improve the service. The services are 
currently sustainable at their current level but 
expansion may face funding challenges. The focus 
must now be in empowering HBs and their leaders 
to implement our seven recommendations and 
deliver a sustainable Wet AMD pathway with five 
core elements for Wales. 
 
Many of our findings are in line with the Health 
Inspectorate Wales Ophthalmology Services 
Thematic Report 2015-16.9 
 
 
 
 
 
 
 
 
 
9 http://hiw.org.uk/docs/hiw/reports/170131opreviewen.pdf 
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ANNEX A: Methodology 
 
 
What we did 
We used a range of research methods to do the evaluation. We asked the HBs for 
financial data, to find out how much the old and new services were costing, the 
numbers and amount of time used by health care professionals delivering the 
services and we also asked for data about the changes to the patients’ vision before 
and after treatment to find out how well the new service was doing compared with 
the old services. We did not compare the pathfinder services with each other 
because the types and numbers of patients, the type of staff the HB had already and 
could potentially recruit varied. The geography and the location of services from 
patients’ homes were also very different in each HB – each HB had unique 
circumstances which enabled different solutions to be tried out. However we did look 
for good practice that could be used in other HBs. 
 
We also asked the HB service mangers and finance staff, the health professionals 
providing the services and patients and carers to meet with our researchers to tell us 
about their experiences of the changes to the old services. The hospital eye services 
experiences were accessed through focus groups, semi-structured interviews and by 
filling in surveys.  
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